ERBB2 and breast carcinoma: In accordance, they express low levels of ERBB2 (erythroblastic leukemia viral oncogene homolog 2, HER-2/neu) in vivo [1], the expression and activity of which confer invasive and metastatic ability to breast cancer cells [4-7].